tiprankstipranks
Trending News
More News >
ONO Pharmaceutical Co Ltd (OPHLF)
OTHER OTC:OPHLF
US Market

ONO Pharmaceutical Co (OPHLF) Financial Statements

Compare
19 Followers

ONO Pharmaceutical Co Financial Overview

ONO Pharmaceutical Co's market cap is currently $6.77B. The company's EPS TTM is $0.30133636; its P/E ratio is 19.86; and it has a dividend yield of 4.16%. ONO Pharmaceutical Co is scheduled to report earnings on October 30, 2025, and the estimated EPS forecast is $0.27. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue¥ 486.87B¥ 502.67B¥ 447.19B¥ 361.36B¥ 309.28B
Gross Profit¥ 338.92B¥ 375.55B¥ 337.13B¥ 267.85B¥ 223.71B
Operating Income¥ 59.75B¥ 163.10B¥ 141.96B¥ 114.91B¥ 92.10B
EBITDA¥ 91.54B¥ 182.10B¥ 161.90B¥ 122.83B¥ 116.85B
Net Income¥ 50.05B¥ 127.98B¥ 112.72B¥ 80.52B¥ 75.42B
Balance Sheet
Cash & Short-Term Investments¥ 210.38B¥ 204.59B¥ 164.29B¥ 116.97B¥ 104.97B
Total Assets¥ 1.06T¥ 913.67B¥ 882.44B¥ 739.20B¥ 746.84B
Total Debt¥ 146.68B¥ 8.86B¥ 9.17B¥ 8.80B¥ 9.05B
Net Debt¥ -57.89B¥ -157.28B¥ -86.97B¥ -60.31B¥ -51.99B
Total Liabilities¥ 275.84B¥ 115.06B¥ 134.62B¥ 77.53B¥ 105.69B
Stockholders' Equity¥ 782.45B¥ 792.96B¥ 741.87B¥ 655.91B¥ 635.55B
Cash Flow
Free Cash Flow¥ 74.47B¥ 89.83B¥ 145.11B¥ 49.55B¥ 53.68B
Operating Cash Flow¥ 82.46B¥ 110.66B¥ 159.61B¥ 61.83B¥ 73.98B
Investing Cash Flow¥ -136.78B¥ 48.08B¥ -100.26B¥ 6.04B¥ -57.59B
Financing Cash Flow¥ 94.30B¥ -89.85B¥ -32.48B¥ -60.24B¥ -24.75B
Currency in JPY

ONO Pharmaceutical Co Earnings and Revenue History

ONO Pharmaceutical Co Debt to Assets

ONO Pharmaceutical Co Cash Flow

ONO Pharmaceutical Co Forecast EPS vs Actual EPS